William J. Link Phd - Sep 16, 2025 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Scott Sieckert, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Sep 16, 2025
Transactions value $
$0
Form type
4
Date filed
9/18/2025, 05:00 PM
Previous filing
Sep 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LINK WILLIAM J PHD Director C/O TARSUS PHARMACEUTICALS, INC., 15440 LAGUNA CANYON ROAD, SUITE 160, IRVINE /s/ Scott Sieckert, Attorney-in-Fact 2025-09-18 0001228684

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Gift $0 -2K -1.4% $0.00 141K Sep 16, 2025 Direct
holding TARS Common Stock 10.4K Sep 16, 2025 By Link Family Enterprise, LP F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP.